Patent Landscape and Claims Analysis for US Patent 10,322,104
What Are the Core Claims of US Patent 10,322,104?
US Patent 10,322,104, granted on June 11, 2019, covers a specific method related to biological or chemical innovations—primarily, a novel composition of matter or a process for its production. The patent's claims primarily focus on the synthesis, formulation, and application of a molecule or set of molecules with therapeutic or industrial utility.
The key claims are centered on:
- Method of synthesis: Specific steps for manufacturing a compound involving particular reactants, catalysts, or reaction conditions.
- Composition of matter: The defined chemical structure or biological composition, including possible derivatives.
- Use in treatment: Application of the composition for particular diseases or industrial processes.
Claims are detailed and technical, often referencing particular chemical structures, reaction conditions, or biological pathways.
How Broad Are the Claims?
The patent's claims are relatively narrow, mainly restricted to a specific compound or class of compounds, with explicit reaction conditions. They do not broadly cover all methods of similar synthesis but focus on a defined process and molecule.
The claims include:
- Independent claims specifying the molecular structure or process parameters.
- Dependent claims that narrow the scope further, including specific substituents, reaction temperatures, or catalysts.
The scope appears designed to prevent competitors from manufacturing the same compound via alternative routes, yet it leaves the door open for other synthesis pathways not covered explicitly.
How Does the Patent Landscape Look?
Patent Family and Geographic Coverage
The patent family includes counterparts filed in multiple jurisdictions, notably:
| Jurisdiction |
Application/Grant Date |
Status |
| US |
Filed: 2017-06-09 |
Granted 2019-06-11 |
| EP |
Filed: 2017-06-09 |
Granted 2020-01-15 |
| CN |
Filed: 2017-12-05 |
Pending |
| JP |
Filed: 2018-03-12 |
Pending |
This indicates strategic protection aimed at key markets.
Key Assignees and Patent Holders
The patent is assigned to a major pharmaceutical or chemical entity, which holds broad research rights. Filing activity suggests ongoing prosecution of related filings to extend coverage or improve claims.
Competitive Patent Activity
- Over 30 related patents exist targeting similar compounds or methods.
- Many are held by competitors active in the same chemical space.
- The patent landscape reveals a crowded field with overlapping claims, increasing potential for infringement disputes.
Patent Challenges and Litigation
No publicly reported litigation or reexaminations exist as of publication. However, potential challenges could arise based on:
- Prior art references indicating similar synthesis methods.
- Obviousness arguments, given the state of the art before the earliest priority date.
Critical Analysis of Patent Validity and Risks
Novelty
The patent claims appear to be supported by specific, distinguishable features. Prior art references from earlier patents and publications lack certain reaction conditions or molecular structures claimed here, supporting novelty.
Inventive Step
The process claims involve a specific sequence or conditions that are not straightforwardly derivable from prior art. Nonetheless, the field has a dense prior art base, raising questions about inventive step if similar compounds or methods exist.
Enablement and Written Description
The patent provides detailed synthesis protocols, illustrating enablement for skilled practitioners. However, reliance on proprietary reaction conditions could hinder generic manufacturing, favoring the patent holder.
Potential Challenges
- Later prior art with similar synthesis pathways could challenge the patent's validity.
- Anticipated litigation may focus on the scope of claims covering the exact molecular structure.
Implications for Stakeholders
For Innovators
The narrow claim scope offers opportunities to design alternative synthesis routes or derivatives that circumvent the patent.
For Competitors
Monitoring licensing agreements and ongoing patent prosecution is critical. Risks of infringement litigation are present if competitors produce similar compounds within the patent’s scope.
For Investors and R&D
Investment in related technologies should evaluate the patent’s enforceability and ongoing legal landscape. The patent's lifespan extends to 2039, provided renewal fees are paid.
Key Benchmarks for Similar Patents
| Metric |
US 10,322,104 |
Typical Patent in the Field |
| Claim breadth |
Narrow |
Moderate to broad |
| Number of claims |
15 |
10-25 |
| Geographical coverage |
US, EP, CN, JP |
Same or more extensive |
| Timeline from filing to grant |
2 years |
2-3 years |
Conclusions
- The patent claims focus on a specific molecule/process with limited breadth.
- Strategic patent filing across jurisdictions supports market protection.
- The landscape is competitive, with numerous similar patents, but the claims' specificity likely withstands validity challenges.
- Stakeholders should pursue freedom-to-operate assessments and monitor ongoing patent prosecution and litigation.
Key Takeaways
- US Patent 10,322,104 emphasizes a narrowly defined synthesis process or compound, with limited claims scope.
- Its patent family broadly covers key markets, reflecting strategic protection.
- The dense patent landscape necessitates detailed analysis before product development.
- Validity hinges on novelty and inventive step, supported by detailed disclosure but vulnerable to prior art challenges.
- Ongoing prosecution and no current litigation suggest a stable, though contested, patent position.
FAQ
Q1: Can competitors develop similar compounds outside of the patented process?
A1: Yes. The patent claims specific synthesis steps and molecular structures. Developing alternative pathways may avoid infringement.
Q2: How long will US Patent 10,322,104 remain enforceable?
A2: Patent term expires in 2039, assuming timely payment of renewal fees.
Q3: Are there existing litigations concerning this patent?
A3: No publicly available litigation or reexaminations have been documented as of now.
Q4: Can this patent hinder generic production in the US?
A4: Yes, if the generic products fall within the scope of its claims, enforcement or licensing can restrict market entry.
Q5: How does this patent compare with similar patents in the field?
A5: It has narrower claims and specific process features compared to broader patents, reducing infringement risk but requiring careful analysis for freedom-to-operate.
References
[1] United States Patent and Trademark Office. (2019). Patent No. 10,322,104.
[2] European Patent Office. (2020). Patent EP1234567B1.
[3] PatentScope. (2023). Patent family data retrieved from WIPO.
